{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:15:32Z","timestamp":1707524132988},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,22]]},"DOI":"10.7759\/cureus.10592","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T20:59:55Z","timestamp":1600808395000},"source":"Crossref","is-referenced-by-count":1,"title":["Local Recurrence Following Total Marrow Radiation: Implications for Clinical Target Delineation"],"prefix":"10.7759","author":[{"given":"Jared H","family":"Hara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang-Hyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Aydogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Koshy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/22373346","article-title":"Volumetric modulated arc therapy: a review of current literature and clinical use in practice","volume":"84","author":"Teoh M","year":"2011","unstructured":"Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A. Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol. 2011, 84:967-996. 10.1259\/bjr\/22373346","journal-title":"Br J Radiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1118\/1.2990779","article-title":"Feasibility study for linac-based intensity modulated total marrow irradiation","volume":"35","author":"Wilkie JR","year":"2008","unstructured":"Wilkie JR, Tiryaki H, Smith BD, Roeske JC, Radosevich JA, Aydogan B. Feasibility study for linac-based intensity modulated total marrow irradiation. Med Phys. 2008, 35:5609-5618. 10.1118\/1.2990779","journal-title":"Med Phys"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/153303460600500508","article-title":"Linac-based intensity modulated total marrow irradiation (IM-TMI)","volume":"5","author":"Aydogan B","year":"2006","unstructured":"Aydogan B, Mundt AJ, Roeske JC. Linac-based intensity modulated total marrow irradiation (IM-TMI). Technol Cancer Res Treat. 2006, 5:513-519. 10.1177\/153303460600500508","journal-title":"Technol Cancer Res Treat"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.11.035","article-title":"Total marrow irradiation with RapidArc volumetric arc therapy","volume":"81","author":"Aydogan B","year":"2011","unstructured":"Aydogan B, Yeginer M, Kavak GO, Fan J, Radosevich JA, Gwe-Ya K. Total marrow irradiation with RapidArc volumetric arc therapy. Int J Radiat Oncol Biol Phys. 2011, 81:592-599. 10.1016\/j.ijrobp.2010.11.035","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.04.071","article-title":"Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation","volume":"73","author":"Wong JY","year":"2009","unstructured":"Wong JY, Rosenthal J, Liu A, Schultheiss T, Forman S, Somlo G. Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation. Int J Radiat Oncol Biol Phys. 2009, 73:273-279. 10.1016\/j.ijrobp.2008.04.071","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1912","article-title":"Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple myeloma","volume":"17","author":"Somlo G","year":"2011","unstructured":"Somlo G, Spielberger R, Frankel P, et al.. Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple myeloma. Clin Cancer Res. 2011, 17:174-182. 10.1158\/1078-0432.CCR-10-1912","journal-title":"Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-288357","article-title":"Phase 1\/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies","volume":"117","author":"Rosenthal J","year":"2011","unstructured":"Rosenthal J, Wong J, Stein A, et al.. Phase 1\/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies. Blood. 2011, 117:309-315. 10.1182\/blood-2010-06-288357","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.06.029","article-title":"Linear accelerator-based intensity-modulated total marrow irradiation technique for treatment of hematologic malignancies: a dosimetric feasibility study","volume":"79","author":"Yeginer M","year":"2011","unstructured":"Yeginer M, Roeske JC, Radosevich JA, Aydogan B. Linear accelerator-based intensity-modulated total marrow irradiation technique for treatment of hematologic malignancies: a dosimetric feasibility study. Int J Radiat Oncol Biol Phys. 2011, 79:1256-1265. 10.1016\/j.ijrobp.2010.06.029","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1118\/1.3668055","article-title":"Verification of dose distribution for volumetric modulated arc therapy total marrow irradiation in a humanlike phantom","volume":"39","author":"Surucu M","year":"2012","unstructured":"Surucu M, Yeginer M, Kavak GO, Fan J, Radosevich JA, Aydogan B. Verification of dose distribution for volumetric modulated arc therapy total marrow irradiation in a humanlike phantom. Med Phys. 2012, 39:281-288. 10.1118\/1.3668055","journal-title":"Med Phys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1390231","article-title":"A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg\/m(2) and total marrow irradiation (TMI) in patients with relapsed\/refractory multiple myeloma","volume":"59","author":"Patel P","year":"2018","unstructured":"Patel P, Oh AL, Koshy M, et al.. A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg\/m(2) and total marrow irradiation (TMI) in patients with relapsed\/refractory multiple myeloma. Leuk Lymphoma. 2018, 59:1666-1671. 10.1080\/10428194.2017.1390231","journal-title":"Leuk Lymphoma"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.09.005","article-title":"Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine\/busulfan: a phase I study","volume":"20","author":"Patel P","year":"2014","unstructured":"Patel P, Aydogan B, Koshy M, et al.. Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine\/busulfan: a phase I study. Biol Blood Marrow Transplant. 2014, 20:2034-2041. 10.1016\/j.bbmt.2014.09.005","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref12","unstructured":"Study of intensity modulated total marrow irradiation (IM-TMI) in addition to fludarabine\/busulfan conditioning for allogeneic transplantation in high risk AML and myelodysplastic syndromes. (2017). Accessed. September 22, 2020: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00988013."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-347872","article-title":"Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007","volume":"119","author":"Dores GM","year":"2012","unstructured":"Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood. 2012, 119:34-43. 10.1182\/blood-2011-04-347872","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10399","article-title":"Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature","volume":"94","author":"Yamauchi K","year":"2002","unstructured":"Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002, 94:1739-1746. 10.1002\/cncr.10399","journal-title":"Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.9057","article-title":"MRI for evaluation of myeloid sarcoma in adults: a single-institution 10-year experience","volume":"199","author":"Shinagare AB","year":"2012","unstructured":"Shinagare AB, Krajewski KM, Hornick JL, Zukotynski K, Kurra V, Jagannathan JP, Ramaiya NH. MRI for evaluation of myeloid sarcoma in adults: a single-institution 10-year experience. AJR Am J Roentgenol. 2012, 199:1193-1198. 10.2214\/AJR.12.9057","journal-title":"AJR Am J Roentgenol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.05.045","article-title":"Use of radiation in extramedullary leukemia\/chloroma: guidelines from the International Lymphoma Radiation Oncology Group","volume":"102","author":"Bakst RL","year":"2018","unstructured":"Bakst RL, Dabaja BS, Specht LK, Yahalom J. Use of radiation in extramedullary leukemia\/chloroma: guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2018, 102:314-319. 10.1016\/j.ijrobp.2018.05.045","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.01.036","article-title":"Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation","volume":"89","author":"Kim JH","year":"2014","unstructured":"Kim JH, Stein A, Tsai N, et al.. Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation. Int J Radiat Oncol Biol Phys. 2014, 89:75-81. 10.1016\/j.ijrobp.2014.01.036","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704223","article-title":"Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course","volume":"32","author":"Lee KH","year":"2003","unstructured":"Lee KH, Lee JH, Choi SJ, et al.. Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course. Bone Marrow Transplant. 2003, 32:835-842. 10.1038\/sj.bmt.1704223","journal-title":"Bone Marrow Transplant"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.03.033","article-title":"Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"85","author":"Wong JY","year":"2013","unstructured":"Wong JY, Forman S, Somlo G, et al.. Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation. Int J Radiat Oncol Biol Phys. 2013, 85:148-156. 10.1016\/j.ijrobp.2012.03.033","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.01.067","article-title":"Phase I trial of total marrow and lymphoid irradiation transplantation conditioning in patients with relapsed\/refractory acute leukemia","volume":"23","author":"Stein A","year":"2017","unstructured":"Stein A, Palmer J, Tsai NC, et al.. Phase I trial of total marrow and lymphoid irradiation transplantation conditioning in patients with relapsed\/refractory acute leukemia. Biol Blood Marrow Transplant. 2017, 23:618-624. 10.1016\/j.bbmt.2017.01.067","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/37416-local-recurrence-following-total-marrow-radiation-implications-for-clinical-target-delineation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:47Z","timestamp":1707506807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/37416-local-recurrence-following-total-marrow-radiation-implications-for-clinical-target-delineation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.10592","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,22]]}}}